Anders Bratt

Patent Attorney
LL.M.

T  +46 8 545 874 03
M  +46 70 622 73 51
anders.bratt@norens.se

Anders Bratt has a PhD from the Karolinska Institute and has a law degree from the University of Uppsala. He has been a patent attorney at Noréns since 2013.

Anders is experienced in patents in the fields of software, pharmaceuticals, diagnostics, biotechnology and medtech. In addition, Anders has expertise in infringement and contractual issues primarily related to patents and designs.

Anders has expert knowledge in biotechnology and pharma regarding, in particular antibodies, immunology, peptides, second medical use and SPCs.

His work at the Karolinska institute involved characterization of proteins involved in angiogenesis, a process critical for tumor growth. During 2008-2013, Anders worked as a patent attorney at another firm, and before that he was a lawyer at RydinCarlsten Advokatbyrå.

Anders is a partner and is the deputy managing partner at Noréns. Anders is authorized to represent clients before the European Patent Office since he is a European patent attorney. He is also a Swedish patent attorney.

Publications:

1: Bratt A, Birot O, Sinha I, Veitonmäki N, Aase K, Ernkvist M, Holmgren L.
Angiomotin regulates endothelial cell-cell junctions and cell motility. J Biol
Chem. 2005 Oct 14;280(41):34859-69. Epub 2005 Jul 25. PubMed PMID: 16043488.

2: Ernkvist M, Aase K, Ukomadu C, Wohlschlegel J, Blackman R, Veitonmäki N, Bratt
A, Dutta A, Holmgren L. p130-angiomotin associates to actin and controls
endothelial cell shape. FEBS J. 2006 May;273(9):2000-11. PubMed PMID: 16640563.

3: Levchenko T, Bratt A, Arbiser JL, Holmgren L. Angiomotin expression promotes
hemangioendothelioma invasion. Oncogene. 2004 Feb 19;23(7):1469-73. PubMed PMID:
14730344.

4: Levchenko T, Aase K, Troyanovsky B, Bratt A, Holmgren L. Loss of
responsiveness to chemotactic factors by deletion of the C-terminal protein
interaction site of angiomotin. J Cell Sci. 2003 Sep 15;116(Pt 18):3803-10. Epub
2003 Aug 5. PubMed PMID: 12902404.

5: Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, Van Meir EG, Holmgren L.
Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ
binding domains. Gene. 2002 Sep 18;298(1):69-77. Erratum in: Gene. 2003 May
22;310;231. Meir, EG [corrected to Van Meir, EG]. PubMed PMID: 12406577.

6: Bergsmedh A, Szeles A, Henriksson M, Bratt A, Folkman MJ, Spetz AL, Holmgren
L. Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad
Sci U S A. 2001 May 22;98(11):6407-11. Epub 2001 May 15. PubMed PMID: 11353826;
PubMed Central PMCID: PMC33481.